Five9, Inc. (NASDAQ:FIVN), a leading provider of cloud contact center
software, today announced that it will attend and sponsor a number of
industry leading contact center events throughout the month of January.
Sign-up for FPL announces plans to install more than 1 million solar panels at three additional solar power plants as part of continued strategy of advancing affordable clean energy in Florida investment picks
In anticipation of Winter Storm Juno – which is threatening much of the
Northeast with blizzard conditions and up to three feet of snow – Fresenius
Medical Care North America (FMCNA), the nation’s leading network of dialysis
facilities, has activated its Incident
Command Team to begin implementing plans to ensure continued patient
care in the areas affected by the storm.
Gannett Co., Inc. (NYSE: GCI) said today that its fourth-quarter 2014
earnings conference call with financial analysts will be held on
Tuesday, February 3 at 10:00 a.m. (ET). The call will be accessible live
to the media and general public via webcast and through a limited number
of listen-only, dial-in conference lines.
Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company has
expanded its hepatitis C generic licensing agreements to include the
investigational NS5A inhibitor GS-5816, which is being evaluated in
Phase 3 clinical studies as part of a single tablet regimen that
combines the compound and sofosbuvir for the treatment of all six
genotypes of hepatitis C.
Company Adjusts 2015 Guidance for FX and Canadian Macroeconomic Headwinds; Now Expects Earnings per Share of $12.60 to $13.60 2014 Highlights
- Sales of $10.0 billion, up 6 percent - Reported EPS of $11.45, up 3 percent - Adjusted EPS of $12.26, up 6 percent CHICAGO , Jan.
Gramercy Property Trust Inc. (NYSE:GPT) , a real estate investment
trust, announced today that it completed a previously announced
expansion of its senior unsecured credit facility (the “Credit
Facility”), increasing the revolving borrowing capacity thereunder by
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.